Challenges and Opportunities in Therapeutic Antibody Development

In collaboration with...

The therapeutic antibody drug market has seen rapid growth with more than 150 antibody drugs now approved or under regulatory review worldwide. Our Innovation Seminar on 'Challenges and Opportunities in Therapeutic Antibody Development,' will talk about future directions in therapeutic antibody development and associated challenges in this rapidly evolving field to help accelerate the future development for novel and more effective treatments.

Programme:

15.00 – Registration and Networking
15.30 – Welcome
15.40 – Keynote
Prof Kai-Michael Toellner - Babraham Institute
16.00 – Company Pitches including:
16.00 Marie Di Placido, Pirbright Institute
Developing tools for foot-and-mouth disease virus cross-reactive antibody discovery
16.20 Jennifer Fleming, Alpha Fold/EBI-EMBL
The intersection between AI and the design of therapeutic antibodies
16.40 Helen Graves, Alchemab Therapeutics
Antibodies From Resilient Individuals: A Novel Approach for Antibody Drug Discovery
17.00 – Tea/Coffee Break
17.20 – Presentation by Sino Biological
Yu-Chih Lin, Sino Biological
Accelerating drug discovery using advances antibody platforms
17.40 – Panel discussion on ‘Opportunities and Challenges of Therapeutic Antibody Development’
18.20 – Closing remarks followed by networking drinks
19.30 - Close

Attendance: This event is free of charge. 

To register, please visit the registration page through this link, click 'Register Here' and submit your details.